Please enable JavaScript to continue using this application.

Compare $MIRM vs $SRRK | Chartloom

Compare

$MIRM vs $SRRK

Mirum Pharmaceuticals Inc · Scholar Rock Holding Corp

MIRM

Mirum Pharmaceuticals Inc

SRRK

Scholar Rock Holding Corp

Compare $MIRM vs $SRRK

Comparing Mirum Pharmaceuticals Inc and Scholar Rock Holding Corp

MIRMMirum Pharmaceuticals Inc

SRRKScholar Rock Holding Corp

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

SRRKScholar Rock Holding Corp

Market cap

$5.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

122.55x

Rev growth (TTM)

—

YTD performance

-1.4%

52W performance

9.0%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MIRM

SRRK

Detailed metrics comparison

MIRM

Mirum Pharmaceuticals Inc

SRRK

Scholar Rock Holding Corp

Market Cap

MIRM$5.24B

SRRK$5.06B

Enterprise Value

MIRM$5.66B

SRRK$4.81B

Price

MIRM$86.01

SRRK$42.19

P/E Ratio

MIRMN/A

SRRKN/A

P/S Ratio

MIRM8.49x

SRRK120.52x

EV/Sales

MIRM9.16x

SRRK115.43x

EV/EBITDA

MIRM2,753.41x

SRRK0.00x

P/B Ratio

MIRM22.21x

SRRK22.46x

P/FCF Ratio

MIRMN/A

SRRKN/A

EV/FCF

MIRM-21.48x

SRRK-16.21x

PEG Ratio

MIRMN/A

SRRKN/A

Forward P/E (NTM)

MIRMN/A

SRRKN/A

Forward P/S (NTM)

MIRM6.85x

SRRK122.55x

Revenue (TTM)

MIRM$618M

SRRK$0

Revenue Growth (YoY)

MIRM44.0%

SRRKN/A

Forward Rev Growth

MIRM17.0%

SRRK2628.0%

Gross Margin (TTM)

MIRM81.7%

SRRK0.0%

Operating Margin (TTM)

MIRM0.0%

SRRK0.0%

EBITDA Margin (TTM)

MIRM-10.6%

SRRK0.0%

Net Margin (TTM)

MIRM-139.2%

SRRK0.0%

FCF Margin (TTM)

MIRM-42.7%

SRRKN/A

Net Income (TTM)

MIRM$-860M

SRRK$-406M

FCF (TTM)

MIRM$-264M

SRRK$-297M

EPS (TTM)

MIRM-$13.57

SRRK-$3.11

ROE (TTM)

MIRM-28933.0%

SRRK-15912.0%

ROA (TTM)

MIRM-9655.0%

SRRK-8660.0%

ROIC (TTM)

MIRM-13639.0%

SRRK-10069.0%

Cash

MIRM$331M

SRRK$437M

Debt

MIRM$750M

SRRK$196M

Net Cash/Debt

MIRM$-419M

SRRK$241M

Current Ratio (TTM)

MIRM2.86x

SRRK7.02x

Quick Ratio (TTM)

MIRM2.62x

SRRK6.84x

Debt/Equity (TTM)

MIRM1.28x

SRRK0.77x

Debt/Assets (TTM)

MIRM0.0%

SRRK0.0%

Interest Coverage (TTM)

MIRMN/A

SRRKN/A

Net Debt/EBITDA (TTM)

MIRM0.00x

SRRK0.00x

Beta

MIRM0.75

SRRK0.76

52W Performance

MIRM18.1%

SRRK9.0%

YTD Performance

MIRM10.2%

SRRK-1.4%

% from 52W High

MIRM-33.8%

SRRK-31.7%

% from 52W Low

MIRM36.0%

SRRK55.9%

Asset Turnover (TTM)

MIRM0.69x

SRRK0.16x

FCF Yield (TTM)

MIRM-5.0%

SRRK-5.9%

Earnings Yield (TTM)

MIRM-16.4%

SRRK-8.0%

Dividend Yield (TTM)

MIRMN/A

SRRKN/A

Rule of 40

MIRM1.3

SRRK0.0

EV/GP/RG

MIRM0.45

SRRKN/A

Ticker research

View MIRM research View SRRK research

Metric	MIRM Mirum Pharmaceuticals Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$5.24B	$5.06B
Enterprise Value	$5.66B	$4.81B
Price	$86.01	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	8.49x	120.52x
EV/Sales	9.16x	115.43x
EV/EBITDA	2,753.41x	0.00x
P/B Ratio	22.21x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.48x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.85x	122.55x
Revenue & Growth
Revenue (TTM)	$618M	$0
Revenue Growth (YoY)	44.0%	N/A
Forward Rev Growth	17.0%	2628.0%
Profitability
Gross Margin (TTM)	81.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10.6%	0.0%
Net Margin (TTM)	-139.2%	0.0%
FCF Margin (TTM)	-42.7%	N/A
Net Income (TTM)	$-860M	$-406M
FCF (TTM)	$-264M	$-297M
EPS (TTM)	-$13.57	-$3.11
ROE (TTM)	-28933.0%	-15912.0%
ROA (TTM)	-9655.0%	-8660.0%
ROIC (TTM)	-13639.0%	-10069.0%
Financial Health
Cash	$331M	$437M
Debt	$750M	$196M
Net Cash/Debt	$-419M	$241M
Current Ratio (TTM)	2.86x	7.02x
Quick Ratio (TTM)	2.62x	6.84x
Debt/Equity (TTM)	1.28x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	0.76
52W Performance	18.1%	9.0%
YTD Performance	10.2%	-1.4%
% from 52W High	-33.8%	-31.7%
% from 52W Low	36.0%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.16x
FCF Yield (TTM)	-5.0%	-5.9%
Earnings Yield (TTM)	-16.4%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1.3	0.0
EV/GP/RG	0.45	N/A
Ticker research	View MIRM research	View SRRK research

Valuation

P/S Ratio

MIRM

8.49x

SRRK

120.52x

EV/FCF

MIRM

-21.48x

SRRK

-16.21x

Growth & revenue

Revenue Growth TTM

MIRM

44.0%

Forward Revenue Growth

SRRK

2628.0%

MIRM

17.0%

Profitability & performance

Gross Margin

MIRM

81.7%

SRRK

0.0%

ROE

SRRK

-15912.0%

MIRM

-28933.0%

FCF Yield %

MIRM

-5.0%

SRRK

-5.9%

52-Week Performance

MIRM

18.1%

SRRK

9.0%

Detailed metrics comparison

MIRM

Mirum Pharmaceuticals Inc

SRRK

Scholar Rock Holding Corp

Market Cap

MIRM$5.24B

SRRK$5.06B

Enterprise Value

MIRM$5.66B

SRRK$4.81B

Price

MIRM$86.01

SRRK$42.19

P/E Ratio

MIRMN/A

SRRKN/A

P/S Ratio

MIRM8.49x

SRRK120.52x

EV/Sales

MIRM9.16x

SRRK115.43x

EV/EBITDA

MIRM2,753.41x

SRRK0.00x

P/B Ratio

MIRM22.21x

SRRK22.46x

P/FCF Ratio

MIRMN/A

SRRKN/A

EV/FCF

MIRM-21.48x

SRRK-16.21x

PEG Ratio

MIRMN/A

SRRKN/A

Forward P/E (NTM)

MIRMN/A

SRRKN/A

Forward P/S (NTM)

MIRM6.85x

SRRK122.55x

Revenue (TTM)

MIRM$618M

SRRK$0

Revenue Growth (YoY)

MIRM44.0%

SRRKN/A

Forward Rev Growth

MIRM17.0%

SRRK2628.0%

Gross Margin (TTM)

MIRM81.7%

SRRK0.0%

Operating Margin (TTM)

MIRM0.0%

SRRK0.0%

EBITDA Margin (TTM)

MIRM-10.6%

SRRK0.0%

Net Margin (TTM)

MIRM-139.2%

SRRK0.0%

FCF Margin (TTM)

MIRM-42.7%

SRRKN/A

Net Income (TTM)

MIRM$-860M

SRRK$-406M

FCF (TTM)

MIRM$-264M

SRRK$-297M

EPS (TTM)

MIRM-$13.57

SRRK-$3.11

ROE (TTM)

MIRM-28933.0%

SRRK-15912.0%

ROA (TTM)

MIRM-9655.0%

SRRK-8660.0%

ROIC (TTM)

MIRM-13639.0%

SRRK-10069.0%

Cash

MIRM$331M

SRRK$437M

Debt

MIRM$750M

SRRK$196M

Net Cash/Debt

MIRM$-419M

SRRK$241M

Current Ratio (TTM)

MIRM2.86x

SRRK7.02x

Quick Ratio (TTM)

MIRM2.62x

SRRK6.84x

Debt/Equity (TTM)

MIRM1.28x

SRRK0.77x

Debt/Assets (TTM)

MIRM0.0%

SRRK0.0%

Interest Coverage (TTM)

MIRMN/A

SRRKN/A

Net Debt/EBITDA (TTM)

MIRM0.00x

SRRK0.00x

Beta

MIRM0.75

SRRK0.76

52W Performance

MIRM18.1%

SRRK9.0%

YTD Performance

MIRM10.2%

SRRK-1.4%

% from 52W High

MIRM-33.8%

SRRK-31.7%

% from 52W Low

MIRM36.0%

SRRK55.9%

Asset Turnover (TTM)

MIRM0.69x

SRRK0.16x

FCF Yield (TTM)

MIRM-5.0%

SRRK-5.9%

Earnings Yield (TTM)

MIRM-16.4%

SRRK-8.0%

Dividend Yield (TTM)

MIRMN/A

SRRKN/A

Rule of 40

MIRM1.3

SRRK0.0

EV/GP/RG

MIRM0.45

SRRKN/A

Ticker research

View MIRM research View SRRK research

Metric	MIRM Mirum Pharmaceuticals Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$5.24B	$5.06B
Enterprise Value	$5.66B	$4.81B
Price	$86.01	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	8.49x	120.52x
EV/Sales	9.16x	115.43x
EV/EBITDA	2,753.41x	0.00x
P/B Ratio	22.21x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.48x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.85x	122.55x
Revenue & Growth
Revenue (TTM)	$618M	$0
Revenue Growth (YoY)	44.0%	N/A
Forward Rev Growth	17.0%	2628.0%
Profitability
Gross Margin (TTM)	81.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10.6%	0.0%
Net Margin (TTM)	-139.2%	0.0%
FCF Margin (TTM)	-42.7%	N/A
Net Income (TTM)	$-860M	$-406M
FCF (TTM)	$-264M	$-297M
EPS (TTM)	-$13.57	-$3.11
ROE (TTM)	-28933.0%	-15912.0%
ROA (TTM)	-9655.0%	-8660.0%
ROIC (TTM)	-13639.0%	-10069.0%
Financial Health
Cash	$331M	$437M
Debt	$750M	$196M
Net Cash/Debt	$-419M	$241M
Current Ratio (TTM)	2.86x	7.02x
Quick Ratio (TTM)	2.62x	6.84x
Debt/Equity (TTM)	1.28x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	0.76
52W Performance	18.1%	9.0%
YTD Performance	10.2%	-1.4%
% from 52W High	-33.8%	-31.7%
% from 52W Low	36.0%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.16x
FCF Yield (TTM)	-5.0%	-5.9%
Earnings Yield (TTM)	-16.4%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1.3	0.0
EV/GP/RG	0.45	N/A
Ticker research	View MIRM research	View SRRK research